Jupiter Neurosciences, Inc. Common Stock (JUNS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.57
• Market Cap: $20.75M
• EPS: $-0.23
• 52-Week High: $3.33
• 52-Week Low: $0.48

Market Sentiment

Jupiter Neurosciences, Inc. Common Stock currently has a Bullish sentiment score of 0.32.

About Jupiter Neurosciences, Inc. Common Stock

Jupiter Neurosciences, Inc. is a clinical-stage biotechnology company headquartered in Jupiter, Florida, specializing in the development of innovative pharmaceutical therapies targeting neuroinflammation-related disorders through its proprietary resveratrol platform. The company is focused on advancing its robust drug development pipeline, aimed at providing breakthrough treatments for various neurological conditions amid a growing demand for effective neurotherapeutics. With a strong commitm...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Jupiter Neurosciences, Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does JUNS pay dividends?

Jupiter Neurosciences, Inc. Common Stock (JUNS) does not currently pay a regular dividend.

What is JUNS's market cap?

Jupiter Neurosciences, Inc. Common Stock (JUNS) has a market capitalization of $20.75M with a current stock price of $0.57.